Neurofibromatosis is a rare disease with the estimation of around one in 3,000 people living with this condition. However, ...

Patients receive exceptional care from a multidisciplinary team of specialists who collaborate in the treatment and management of NF and its complications. Dr. Bruce Korf, medical geneticist, ...

The Consortium consists of thirteen primary and ten affiliate clinical centers around the US and Australia with an Operations Center at the University of Alabama at Birmingham to coordinate consortium ...

Von Recklinghausen disease (VRD) is also called neurofibromatosis type 1 (NF1). It is a genetic disorder in which the growth of nervous tissue is altered, producing tumors related to the nerve sheath.

Vykat XR is specifically indicated to address hyperphagia, or the abnormally strong sensation of hunger, which often leads to ...

The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I ...

RXRX's CDK7 inhibitor REC-617 has demonstrated activity, but additional data from the ELUCIDATE trial in various solid tumors ...

Reivi Dela Cruz was only four years old when he was diagnosed with Neurofibromatosis Type 1 (NF1), a genetic condition that causes tumors (neurofibromas, which are usually non-cancerous) to grow on or ...

Authorities from the Cuban Health System assured this Friday that the medical care provided to a 10-year-old boy in several institutions was uneventful, a case that was the subject of manipulation on ...

CAMBRIDGE, England--(BUSINESS WIRE)--Healx, an AI-enabled, clinical-stage biotech company dedicated to rare diseases, today announced the first patient has been dosed in INSPIRE-NF1, a Phase 2 ...